Literature DB >> 33939525

Are SGLT2 Inhibitors New Hypertension Drugs?

Kazuomi Kario1, Keith C Ferdinand2, Wanpen Vongpatanasin3.   

Abstract

Entities:  

Keywords:  Editorials; drug therapy; hypertension; sodium-glucose transporter 2 inhibitors

Year:  2021        PMID： 33939525     DOI： 10.1161/CIRCULATIONAHA.121.053709

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

Review 1.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

2.  SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na+ transport in Dahl SS rats.

Authors:  Olha Kravtsova; Ruslan Bohovyk; Vladislav Levchenko; Oleg Palygin; Christine A Klemens; Timo Rieg; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-25

3.  Latest hypertension research to inform clinical practice in Asia.

Authors:  Kazuomi Kario; Masaki Mogi; Satoshi Hoshide
Journal:  Hypertens Res       Date:  2022-04-05       Impact factor: 5.528

Review 4.  Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Saulat Siddique; Yuda Turana; Yan Li; Chen-Huan Chen; Jennifer Nailes; Minh Van Huynh; Peera Buranakitjaroen; Hao-Min Cheng; Takeshi Fujiwara; Satoshi Hoshide; Michiaki Nagai; Sungha Park; Jinho Shin; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-02-16       Impact factor: 3.738

5.  Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.

Authors:  Anne Zanchi; Menno Pruijm; Marie-Eve Muller; Arlène Ghajarzadeh-Wurzner; Marc Maillard; Nathalie Dufour; Olivier Bonny; Grégoire Wuerzner; Michel Burnier
Journal:  Front Cardiovasc Med       Date:  2022-03-22

Review 6.  Rethinking Resistant Hypertension.

Authors:  Gabrielle Bourque; Swapnil Hiremath
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

7.  Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway.

Authors:  Juliana Cordovil Cotrin; Gabriel Santos Martins de Souza; Tamiris Ingrid Petito-da-Silva; Luiz Eduardo Macedo Cardoso; Vanessa Souza-Mello; Sandra Barbosa-da-Silva
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-01-18       Impact factor: 1.636

8.  Sympathetic modulation by antihypertensive drugs.

Authors:  Kenichi Katsurada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-03       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.